In last trading session, ENDRA Life Sciences Inc. (NASDAQ:NDRA) saw 0.41 million shares changing hands with its beta currently measuring 1.00. Company’s recent per share price level of $0.16 trading at -$0.01 or -5.49% at ring of the bell on the day assigns it a market valuation of $10.71M. That closing price of NDRA’s stock is at a discount of -581.25% from its 52-week high price of $1.09 and is indicating a discount of -6.25% from its 52-week low price of $0.17. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.31 million shares which gives us an average trading volume of 275.85K if we extend that period to 3-months.
ENDRA Life Sciences Inc. (NASDAQ:NDRA) trade information
Upright in the red during last session for losing -5.49%, in the last five days NDRA remained trading in the red while hitting it’s week-highest on Tuesday, 11/22/22 when the stock touched $0.16 price level, adding 17.95% to its value on the day. ENDRA Life Sciences Inc.’s shares saw a change of -76.37% in year-to-date performance and have moved -9.17% in past 5-day. ENDRA Life Sciences Inc. (NASDAQ:NDRA) showed a performance of -50.45% in past 30-days. Number of shares sold short was 0.68 million shares which calculate 3.18 days to cover the short interests.
ENDRA Life Sciences Inc. (NDRA) estimates and forecasts
Statistics highlight that ENDRA Life Sciences Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -21.39% of value to its shares in past 6 months, showing an annual growth rate of 25.00% while that of industry is 0.40. Apart from that, the company came raising its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 16.70% in the current quarter and calculating 50.00% increase in the next quarter.
And 2 analysts are in estimates of company making revenue of $850k in the next quarter that will end on Dec 2022.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 18.30% during past 5 years.
ENDRA Life Sciences Inc. is more likely to be releasing its next quarterly report between November 14 and November 18 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
ENDRA Life Sciences Inc. (NASDAQ:NDRA)’s Major holders
Insiders are in possession of 1.85% of company’s total shares while institution are holding 7.00 percent of that, with stock having share float percentage of 7.13%. Investors also watch the number of corporate investors in a company very closely, which is 7.00% institutions for ENDRA Life Sciences Inc. that are currently holding shares of the company. Vanguard Group, Inc. (The) is the top institutional holder at NDRA for having 1.17 million shares of worth $0.27 million. And as of Jun 29, 2022, it was holding 1.85% of the company’s outstanding shares.
The second largest institutional holder is Morgan Stanley, which was holding about 0.85 million shares on Jun 29, 2022. The number of shares represents firm’s hold over 1.35% of outstanding shares, having a total worth of $0.2 million.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2022, the former fund manager was holding 0.64 million shares of worth $0.15 million or 1.01% of the total outstanding shares. The later fund manager was in possession of 0.51 million shares on Jun 29, 2022, making its stake of worth around $0.12 million in the company or a holder of 0.81% of company’s stock.